Influenza A virus vaccine H3N2 (sanofi pasteur)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus vaccine H3N2 (sanofi pasteur)
Drug Alias NameH3N2v vaccineMonovalent inactivated influenza H3N2 variant vaccineMonovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203 vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A